Related Experiment Video
Updated: Jun 18, 2026
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
[Diagnosis and treatment of autoimmune hepatitis]
Bart J Verwer1, Gerd Bouma, Elisabeth Bloemena
1VU medisch centrum, Amsterdam, The Netherlands. b.verwer@vumc.nl
Insights
Autoimmune hepatitis (AIH) is a chronic liver disease diagnosed by clinical, biochemical, and histological findings. Effective management can improve quality of life and prolong survival, though a cure is not yet available.
Area of Science:
- Hepatology
- Immunology
Background:
- Autoimmune hepatitis (AIH) is a progressive, chronic liver disease of unknown etiology affecting all age groups.
- Diagnosis relies on clinical presentation, biochemical markers, exclusion of other hepatitis causes, and histopathology.
Observation:
- Case 1: A 22-year-old woman with fulminant hepatitis and jaundice achieved remission with corticosteroids and azathioprine.
- Case 2: A 48-year-old woman with AIH-related cirrhosis and hepatocellular carcinoma was considered for transplantation.
- Case 3: An 81-year-old man with impaired liver function and cirrhosis also achieved remission with similar treatment.
Findings:
- AIH presents with diverse symptoms, highlighting the need for timely diagnosis.
- Corticosteroids and azathioprine demonstrated efficacy in inducing remission across different patient profiles.
- Hepatocellular carcinoma can develop in patients with AIH-induced cirrhosis.
Implications:
- Appropriate management of AIH can significantly improve patient outcomes, including prolonged survival and enhanced quality of life.
- While no cure exists, effective treatment strategies may obviate the need for liver transplantation.
- These cases underscore the importance of recognizing AIH's varied clinical manifestations and managing it proactively.
Abstract:
Autoimmune hepatitis (AIH) is a progressive, chronic form of hepatitis of unknown cause that occurs in people of all ages. The diagnosis is based on characteristic clinical and biochemical abnormalities, absence of other causes of hepatitis and histopathological characteristics. The variety of symptoms that AIH patients may have and the importance of considering the disease is illustrated in three case studies. The first was a 22-year-old woman with fulminant hepatitis and jaundice. Corticosteroid and azathioprine treatment resulted in prolonged remission. The second patient, a 48-year-old woman, had hepatocellular carcinoma in a cirrhotic liver, based on AIH. Radiofrequency ablation was planned, after which the patient would be put on the waiting list for transplantation. The third patient was an 81-year-old man with impaired liver function and cirrhosis. His treatment was the same as in the first patient and resulted in remission as well. No curative therapy for AIH is yet available, but appropriate management of the disease can prolong survival, improve the quality of life, and avoid the need for liver transplantation.
Related Concept Videos
01:25Hepatitis
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:28Viral Hepatitis I: Introduction
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...